Understanding breast cancer risk -- where do we stand in 2005?
- PMID: 15784178
- PMCID: PMC6741339
- DOI: 10.1111/j.1582-4934.2005.tb00350.x
Understanding breast cancer risk -- where do we stand in 2005?
Abstract
Breast cancer is the most frequent cancer in women and represents the second leading cause of cancer death among women (after lung cancer). The etiology of breast cancer is still poorly understood with known breast cancer risk factors explaining only a small proportion of cases. Risk factors that modulate the development of breast cancer discussed in this review include: age, geographic location (country of origin) and socioeconomic status, reproductive events, exogenous hormones, lifestyle risk factors (alcohol, diet, obesity and physical activity), familial history of breast cancer, mammographic density, history of benign breast disease, ionizing radiation, bone density, height, IGF- 1 and prolactin levels, chemopreventive agents. Additionally, we summarized breast cancer risk associated with the following genetic factors: breast cancer susceptibility high-penetrance genes (BRCA1, BRCA2, p53, PTEN, ATM, NBS1 or LKB1) and low-penetrance genes such as cytochrome P450 genes (CYP1A1, CYP2D6, CYP19), glutathione S-transferase family (GSTM1, GSTP1), alcohol and one-carbon metabolism genes (ADH1C and MTHFR), DNA repair genes (XRCC1, XRCC3, ERCC4/XPF) and genes encoding cell signaling molecules (PR, ER, TNFalpha or HSP70). All these factors contribute to a better understanding of breast cancer risk. Nonetheless, in order to evaluate more accurately the overall risk of breast tumorigenesis, novel genetic and phenotypic traits need to be identified.
Similar articles
-
Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.Breast. 2016 Aug;28:136-44. doi: 10.1016/j.breast.2016.05.006. Epub 2016 Jun 16. Breast. 2016. PMID: 27318168 Review.
-
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27. Breast Cancer Res Treat. 2006. PMID: 16261400
-
Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.Eur J Surg Oncol. 2015 May;41(5):641-6. doi: 10.1016/j.ejso.2015.01.021. Epub 2015 Feb 17. Eur J Surg Oncol. 2015. PMID: 25736863
-
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8. Breast Cancer Res Treat. 2004. PMID: 15564800
-
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.Biol Res. 2017 Oct 6;50(1):35. doi: 10.1186/s40659-017-0139-2. Biol Res. 2017. PMID: 28985766 Free PMC article. Review.
Cited by
-
Time trends in municipal distribution patterns of cancer mortality in Spain.BMC Cancer. 2014 Jul 24;14:535. doi: 10.1186/1471-2407-14-535. BMC Cancer. 2014. PMID: 25060700 Free PMC article.
-
In-Vitro Fertilization Impact on the Risk of Breast Cancer: A Review Article.Iran J Public Health. 2021 Mar;50(3):438-447. doi: 10.18502/ijph.v50i3.5583. Iran J Public Health. 2021. PMID: 34178791 Free PMC article. Review.
-
CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.Iran J Public Health. 2017 Apr;46(4):537-544. Iran J Public Health. 2017. PMID: 28540271 Free PMC article.
-
An investigation of breast cancer risk factors in Cyprus: a case control study.BMC Cancer. 2010 Aug 23;10:447. doi: 10.1186/1471-2407-10-447. BMC Cancer. 2010. PMID: 20727220 Free PMC article.
-
Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses.Iran J Med Sci. 2018 Jul;43(4):355-364. Iran J Med Sci. 2018. PMID: 30046203 Free PMC article. Review.
References
-
- Parkin D. M., International variation, Oncogene, 23: 6329–6340, 2004. - PubMed
-
- Stewart S. L., King J. B., Thompson T. D., Friedman C., Wingo P. A., Cancer mortality surveillance–United States, 1990–2000, MMWR. Surveill. Summ., 53: 1–108, 2004. - PubMed
-
- Jemal A., Thomas A., Murray T., Thun M., Cancer statistics, 2002, CA Cancer. J.Clin., 52: 23–47, 2002. - PubMed
-
- Bray F., Sankila R., Ferlay J., Parkin D. M., Estimates of cancer incidence and mortality in Europe in 1995, Eur. J. Cancer, 38: 99–166, 2002. - PubMed
-
- Edwards B. K., Howe H. L., Ries L. A., Thun M. J., Rosenberg H. M., Yancik R., Wingo P. A., Jemal A., Feigal E. G., Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and againg on U.S. Cancer burden, Cancer, 94: 2766–2792, 2002. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous